Table 2

Summary of immunolabeling and in situ hybridization labeling studies with human prostate tissue specimens (n = 149 total)

Note that the immunolabeling and in situ labeling were carried out on adjacent sections from each specimen.

No. of prostates assayedPathologyGleason scoreImmunolabelingISHa
5Normal000
15SV000
2SV0+10
20BPH000
7BPH0+10
11HGPIN+1+1
1HGPIN+3+3
1PCA6+1+2
2PCA6+2+2
23PCA6+3+2
1PCA7+1+2
2PCA7+2+3
18PCA7+3+2
1PCA8+1+3
23PCA8+2+2
7PCA9+3+3
10PCA10+3+3
  • a ISH, in situ hybridization; SV, seminal vesicle; BPH, benign prostatic hyperplasia; HGPIN, high-grade prostatic intraepithelial neoplasia; PCA, prostate cancer adenocarcinoma.